Kristian Stengaard-Pedersen

Up-regulated dipeptidyl-peptidase IV (CD26) on monocytes was unaffected by effective DMARD treatment in early steroid and DMARD-naive rheumatoid arthritis

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • T Ellingsen, Denmark
  • I Hansen, Denmark
  • J Thorsen, Denmark
  • Bjarne Kuno Møller
  • U Tarp, Denmark
  • Søren Jacobsen, Reumatologisk Afdeling, Rigshospitalet, Denmark
  • M Lund Hetland, Reumatologisk Afdeling, Glostrup Hospital
  • ,
  • A Vestergaard, Denmark
  • Kim Hørslev-Petersen, Center Sønderjylland, Denmark
  • K Stengaard-Pedersen
To study the CD26 density on monocytes and CD4+ T-lymphocytes in steroid and DMARD-naïve, early rheumatoid arthritis (RA) patients and to analyse for correlations with disease activity, including long-term radiographic progression.
Original languageEnglish
JournalClinical and Experimental Rheumatology
Pages (from-to)58-63
Number of pages6
Publication statusPublished - 2013

    Research areas

  • Adult, Aged, Antirheumatic Agents, Arthritis, Rheumatoid, CD4-Positive T-Lymphocytes, Cyclosporine, Dipeptidyl Peptidase 4, Disease Progression, Drug Therapy, Combination, Female, Humans, Male, Methotrexate, Middle Aged, Monocytes, Treatment Outcome

See relations at Aarhus University Citationformats

ID: 52849876